Reported Saturday, Edwards Lifesciences Presents Ten-Year COMMENCE Trial Results Reinforcing Long-Term Durability Of RESILIA Tissue In Aortic Valve Patients

Benzinga Newsdesk www.benzinga.com Positive 91.8%

Neg 0% Neu 0% Pos 91.8%

Comments

No comments yet. Be the first!